Effect of Intravenous Golimumab on Fatigue and the Relationship with Clinical Response in Adults with Active Ankylosing Spondylitis in the Phase 3 GO-ALIVE Study

INTRODUCTION: We studied the effect of intravenous (IV)-golimumab on fatigue and the association of fatigue improvement with clinical response post hoc in adults with active ankylosing spondylitis (AS) in the GO-ALIVE trial. METHODS: Patients were randomized to IV-golimumab 2 mg/kg (N = 105) at week...

Descripción completa

Detalles Bibliográficos
Autores principales: Deodhar, Atul, Shiff, Natalie J., Gong, Cinty, Chan, Eric K. H., Hsia, Elizabeth C., Lo, Kim Hung, Akawung, Alianu, Kim, Lilianne, Xu, Stephen, Reveille, John D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2023
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10326229/
https://www.ncbi.nlm.nih.gov/pubmed/37322274
http://dx.doi.org/10.1007/s40744-023-00556-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10326229/
https://www.ncbi.nlm.nih.gov/pubmed/37322274
http://dx.doi.org/10.1007/s40744-023-00556-y

Ejemplares similares